Literature DB >> 16341934

Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.

Tomohiro Tatsuta1, Nobue Kitanaka, Junichi Kitanaka, Yoshio Morita, Motohiko Takemura.   

Abstract

In male ICR mice, a single intraperitoneal administration of methamphetamine (METH) (10 mg/kg) induced stereotyped behavior such as continuous sniffing, circling, and nail biting, reaching a plateau level 20 min after the injection. Subcutaneous pretreatment with clorgyline, a monoamine oxidase (MAO)-A inhibitor, at a dose of 0.1 mg/kg 2 h prior to the drug challenge significantly decreased the initial (first 20 min) intensity of stereotypies and increased the latency to onset. The effect was not observed with either higher doses of clorgyline (1 and 10 mg/kg) or l-deprenyl, a MAO-B inhibitor, at doses of 0.1-10 mg/kg. In male Wistar rats, the inhibitory effect of clorgyline on METH-induced stereotypy was not observed. Pretreatment of the mice with clorgyline (0.1 mg/kg) had no effect on apparent serotonin and dopamine turnover in the striatum, although the higher doses of clorgyline (1 and 10 mg/kg) significantly decreased the turnover. These results suggest that a low dose of clorgyline tends to increase the latency and decrease the intensity of stereotypies induced by METH in a dopamine metabolism-independent manner in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341934     DOI: 10.1007/s11064-005-8390-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

1.  The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.

Authors:  J M Delfs; A E Kelley
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

Review 2.  Substrate-selective monoamine oxidases--inhibitor, tissue, species and functional differences.

Authors:  D L Murphy
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 3.  Catecholamines in the brain as mediators of amphetamine psychosis.

Authors:  S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1972-08

4.  Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study.

Authors:  F Fornai; K Chen; F S Giorgi; M Gesi; M G Alessandri; J C Shih
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.

Authors:  Nicholas MacInnes; Sheila L Handley
Journal:  Eur J Pharmacol       Date:  2005-06-01       Impact factor: 4.432

Review 6.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

7.  Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.

Authors:  B Levant; J D Moehlenkamp; K A Morgan; N L Leonard; C C Cheng
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

8.  Repeated clorgyline treatment inhibits methamphetamine-induced behavioral sensitization in mice.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

9.  Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.

Authors:  K E Culver; J M Rosenfeld; H Szechtman
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

10.  Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.

Authors:  T Nishikawa; N Mataga; M Takashima; M Toru
Journal:  Eur J Pharmacol       Date:  1983-03-25       Impact factor: 4.432

View more
  8 in total

1.  Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

2.  Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Tomohiro Tatsuta; Kaname Watabe; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

3.  Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs.

Authors:  Paolo Dell'Antone; Meryem IbnLkayat; Denise Drago; Paolo Zatta
Journal:  Metab Brain Dis       Date:  2007-07-12       Impact factor: 3.584

4.  Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

Authors:  J Kitanaka; N Kitanaka; T Tatsuta; F S Hall; G R Uhl; K Tanaka; N Nishiyama; Y Morita; M Takemura
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

5.  Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice.

Authors:  Tomohiro Tatsuta; Nobue Kitanaka; Junichi Kitanaka; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

6.  Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2006-11-09

7.  The ethyl acetate fraction of a methanolic extract of unripe noni (Morinda citrifolia Linn.) fruit exhibits a biphasic effect on the dopaminergic system in mice.

Authors:  Vijayapandi Pandy; Megala Narasingam; Kamini Vijeepallam; Syam Mohan; Vasudevan Mani; Zahurin Mohamed
Journal:  Exp Anim       Date:  2017-04-26

8.  Effects of ethanol on the toxicokinetics of methamphetamine in rabbits.

Authors:  Bing Li; Yujin Wang; Yun Zhang; Meili Liu
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.